| UniProt ID | DUS16_HUMAN | |
|---|---|---|
| UniProt AC | Q9BY84 | |
| Protein Name | Dual specificity protein phosphatase 16 | |
| Gene Name | DUSP16 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 665 | |
| Subcellular Localization | Cytoplasm. Nucleus. Cytoplasmic vesicle. After dissociation upon AGTR stimulation, re-associates with ARRB2 on endocytic vesicles. | |
| Protein Description | Dual specificity protein phosphatase involved in the inactivation of MAP kinases. Dephosphorylates MAPK10 bound to ARRB2.. | |
| Protein Sequence | MAHEMIGTQIVTERLVALLESGTEKVLLIDSRPFVEYNTSHILEAININCSKLMKRRLQQDKVLITELIQHSAKHKVDIDCSQKVVVYDQSSQDVASLSSDCFLTVLLGKLEKSFNSVHLLAGGFAEFSRCFPGLCEGKSTLVPTCISQPCLPVANIGPTRILPNLYLGCQRDVLNKELMQQNGIGYVLNASNTCPKPDFIPESHFLRVPVNDSFCEKILPWLDKSVDFIEKAKASNGCVLVHCLAGISRSATIAIAYIMKRMDMSLDEAYRFVKEKRPTISPNFNFLGQLLDYEKKIKNQTGASGPKSKLKLLHLEKPNEPVPAVSEGGQKSETPLSPPCADSATSEAAGQRPVHPASVPSVPSVQPSLLEDSPLVQALSGLHLSADRLEDSNKLKRSFSLDIKSVSYSASMAASLHGFSSSEDALEYYKPSTTLDGTNKLCQFSPVQELSEQTPETSPDKEEASIPKKLQTARPSDSQSKRLHSVRTSSSGTAQRSLLSPLHRSGSVEDNYHTSFLFGLSTSQQHLTKSAGLGLKGWHSDILAPQTSTPSLTSSWYFATESSHFYSASAIYGGSASYSAYSCSQLPTCGDQVYSVRRRQKPSDRADSRRSWHEESPFEKQFKRRSCQMEFGESIMSENRSREELGKVGSQSSFSGSMEIIEVS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 8 | Phosphorylation | MAHEMIGTQIVTERL CCCCHHCCHHHHHHH | 12.28 | 24043423 | |
| 12 | Phosphorylation | MIGTQIVTERLVALL HHCCHHHHHHHHHHH | 19.60 | 24043423 | |
| 55 | Acetylation | INCSKLMKRRLQQDK CCHHHHHHHHHHHCH | 44.81 | 22547814 | |
| 82 | Phosphorylation | HKVDIDCSQKVVVYD CCCCCCCCCCEEEEE | 29.32 | - | |
| 145 | Phosphorylation | GKSTLVPTCISQPCL CCCCCCEEECCCCCC | 18.26 | 28348404 | |
| 148 | Phosphorylation | TLVPTCISQPCLPVA CCCEEECCCCCCCCC | 30.16 | 24719451 | |
| 218 | Ubiquitination | VNDSFCEKILPWLDK CCCHHHHHHHHHHHH | 51.21 | - | |
| 225 | Ubiquitination | KILPWLDKSVDFIEK HHHHHHHHCHHHHHH | 50.65 | - | |
| 232 | Ubiquitination | KSVDFIEKAKASNGC HCHHHHHHHHHCCCE | 50.82 | - | |
| 399 | Phosphorylation | DSNKLKRSFSLDIKS CCCCHHHEEEEECCE | 20.01 | 29514088 | |
| 401 | Phosphorylation | NKLKRSFSLDIKSVS CCHHHEEEEECCEEE | 26.78 | 25159151 | |
| 446 | Phosphorylation | TNKLCQFSPVQELSE CCCCCCCCCHHHHHH | 9.78 | 30266825 | |
| 452 | Phosphorylation | FSPVQELSEQTPETS CCCHHHHHHCCCCCC | 27.23 | 30266825 | |
| 455 | Phosphorylation | VQELSEQTPETSPDK HHHHHHCCCCCCCCH | 21.02 | 30266825 | |
| 458 | Phosphorylation | LSEQTPETSPDKEEA HHHCCCCCCCCHHHC | 46.92 | 30266825 | |
| 459 | Phosphorylation | SEQTPETSPDKEEAS HHCCCCCCCCHHHCC | 29.46 | 30266825 | |
| 466 | Phosphorylation | SPDKEEASIPKKLQT CCCHHHCCCCHHHHC | 42.58 | 27251275 | |
| 473 | Phosphorylation | SIPKKLQTARPSDSQ CCCHHHHCCCCCCHH | 34.76 | 25072903 | |
| 477 | Phosphorylation | KLQTARPSDSQSKRL HHHCCCCCCHHHCCC | 44.32 | 25072903 | |
| 479 | Phosphorylation | QTARPSDSQSKRLHS HCCCCCCHHHCCCEE | 40.46 | 25072903 | |
| 481 | Phosphorylation | ARPSDSQSKRLHSVR CCCCCHHHCCCEEEE | 24.56 | 25072903 | |
| 498 | Phosphorylation | SSGTAQRSLLSPLHR CCCHHHHHHCCCCCC | 22.91 | 23403867 | |
| 501 | Phosphorylation | TAQRSLLSPLHRSGS HHHHHHCCCCCCCCC | 30.61 | 23898821 | |
| 506 | Phosphorylation | LLSPLHRSGSVEDNY HCCCCCCCCCCCCCC | 25.36 | 24719451 | |
| 508 | Phosphorylation | SPLHRSGSVEDNYHT CCCCCCCCCCCCCCH | 24.47 | 28857561 | |
| 515 | Phosphorylation | SVEDNYHTSFLFGLS CCCCCCCHHHHCCCC | 15.71 | 28348404 | |
| 516 | Phosphorylation | VEDNYHTSFLFGLST CCCCCCHHHHCCCCC | 13.46 | 28348404 | |
| 604 | Phosphorylation | VRRRQKPSDRADSRR HHCCCCCCCCCHHHH | 46.92 | - | |
| 609 | Phosphorylation | KPSDRADSRRSWHEE CCCCCCHHHHCCCCC | 28.71 | 23403867 | |
| 612 | Phosphorylation | DRADSRRSWHEESPF CCCHHHHCCCCCCHH | 31.51 | 30266825 | |
| 617 | Phosphorylation | RRSWHEESPFEKQFK HHCCCCCCHHHHHHH | 31.72 | 26330541 | |
| 627 | Phosphorylation | EKQFKRRSCQMEFGE HHHHHHHHHHHHHHH | 16.85 | 30576142 | |
| 635 | Phosphorylation | CQMEFGESIMSENRS HHHHHHHHHHCCCCC | 24.78 | 28348404 | |
| 638 | Phosphorylation | EFGESIMSENRSREE HHHHHHHCCCCCHHH | 30.01 | 28348404 | |
| 642 | Phosphorylation | SIMSENRSREELGKV HHHCCCCCHHHHHCC | 56.47 | 28348404 | |
| 658 | Phosphorylation | SQSSFSGSMEIIEVS CCCCCCCCCEEEEEC | 16.43 | 27251275 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 446 | S | Phosphorylation | Kinase | MK01 | P28482 | PhosphoELM |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DUS16_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MK14_HUMAN | MAPK14 | physical | 11359773 | |
| MK09_HUMAN | MAPK9 | physical | 11359773 | |
| MK10_HUMAN | MAPK10 | physical | 11359773 | |
| MK01_HUMAN | MAPK1 | physical | 11489891 | |
| MK08_HUMAN | MAPK8 | physical | 11489891 | |
| MK14_HUMAN | MAPK14 | physical | 11489891 | |
| MK14_HUMAN | MAPK14 | physical | 27880917 | |
| MK09_HUMAN | MAPK9 | physical | 27880917 | |
| DUS16_HUMAN | DUSP16 | physical | 27432908 | |
| MLF1_HUMAN | MLF1 | physical | 27432908 | |
| TEBP_HUMAN | PTGES3 | physical | 27432908 | |
| MK09_HUMAN | MAPK9 | physical | 27432908 | |
| NXF2_HUMAN | NXF2 | physical | 27432908 | |
| MK08_HUMAN | MAPK8 | physical | 27432908 | |
| AIP_HUMAN | AIP | physical | 27432908 | |
| KCD20_HUMAN | KCTD20 | physical | 27432908 | |
| 1433B_HUMAN | YWHAB | physical | 27432908 | |
| HSPB1_HUMAN | HSPB1 | physical | 27432908 | |
| HIG1A_HUMAN | HIGD1A | physical | 27432908 | |
| MK14_HUMAN | MAPK14 | physical | 27432908 | |
| ARF5_HUMAN | ARF5 | physical | 27432908 | |
| DNJB1_HUMAN | DNAJB1 | physical | 27432908 | |
| PFD3_HUMAN | VBP1 | physical | 27432908 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-501, AND MASSSPECTROMETRY. | |
| "Activation of ERK induces phosphorylation of MAPK phosphatase-7, aJNK specific phosphatase, at Ser-446."; Masuda K., Shima H., Katagiri C., Kikuchi K.; J. Biol. Chem. 278:32448-32456(2003). Cited for: PHOSPHORYLATION AT SER-446. | |